If Amazon sent you this:
The notice tells you to remove the claim and appeal. It also contains one sentence most sellers skim past — if the claim is on your physical packaging, there may be no path back for that ASIN at all. Knowing which situation you are in decides whether you spend two days or two months.
The notice reads:
This product has been identified as a supplement, consumable product, cosmetic, or topical product that makes prohibited disease claims. Products that make disease claims are prohibited from sale and listing on Amazon. For more information, please see: [Seller Central policy link] For reinstatement, please remove the prohibited disease claim from the detail page and appeal the restriction. Please note that if the disease claim is on the product labeling, there may not be a path to reinstatement.
Most sellers read the first two sentences, remove some wording, and appeal.
Read the last sentence again. It is doing far more work than its placement suggests, and it determines whether this costs you two days or ends the ASIN permanently.
There are two versions of this notice, and they are not close to equivalent.
The claim is in your listing content — title, bullets, description, A+ content, backend search terms. This is recoverable. Remove it, appeal, move on.
The claim is on your physical packaging — printed on the label, visible in your product images. This one may not be recoverable at all, and continuing to appeal will not change that.
So before you edit anything, go and look at your own label. Not the listing. The pack.
Amazon’s position, as stated to sellers directly: reformulating a label does not make the existing ASIN compliant. Remove the claims from the product label and create a new ASIN for the corrected product.
That is worth stating plainly, because it is the opposite of what almost everyone assumes. The ASIN does not come back once a prohibited claim has been on the packaging associated with it. Updating the artwork does not clear it. Sending new photographs does not clear it. Appealing repeatedly does not clear it.
The path is: fix the packaging, generate a new UPC, create a new listing, and rebuild that product’s history from zero. Painful — and considerably less painful than discovering it after two months of appeals.
This is the most common reaction, and it is wrong more often than it is right.
One seller was flagged on a culinary spice and was certain it was an error — no supplement positioning, no medical language, an ordinary grocery item. The offending text was a single line printed in the bottom corner of the pack, noting that the spices may offer benefits such as potent anti-inflammatory properties and antioxidants.
That is a disease claim. It was on the label. The ASIN was not recoverable.
Things that count and routinely surprise people:
Detection is automated. It reads your images. It does not know what you meant.
If your first appeal argued the flag was mistaken, the reply is usually this:
We have received your request for review of the following product(s) and after careful consideration have determined that the product(s) does not meet the necessary criteria and will be restricted post the grace period.
It is a template. It does not mean anyone weighed your argument, and it carries no information about what specifically is wrong. Treat it as a signal to go and find the offending wording rather than as an invitation to explain yourself more clearly.
Amazon’s compliance review reads your whole product — listing text, backend fields, images and label artwork — not the part you were thinking about when you wrote the copy. The most expensive mistake in this category is assuming a claim lives where you put it, when the review is looking at a photograph of your packaging.
Keep reading: How to fix a listing suppressed for an ingredient claim · Reinstating after a cGMP deactivation · When you actually need a Prop 65 warning
Background reading: What actually triggers a supplement listing suppression.
Tell us what Amazon sent and what you have already tried. We work supplement suppressions and compliance deactivations every week — if it is fixable, we will tell you how, and if it is not, we will tell you that too.
Published August 27, 2026 · Last reviewed August 27, 2026